A relationship between 5-lipoxygenase-activating protein and bcl-x(L) expression in murine pro-B lymphocytic FL5.12 cells

Kaushik Datta, Shyam S. Biswal, Jie Xu, Kelly M. Towndrow, Xiang Feng, James P. Kehrer

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


Inhibitors of 5-lipoxygenase-activating protein (FLAP) have been found to induce apoptosis. The current study examined the expression of FLAP and bcl family proteins and the induction of apoptosis in interleukin-3-dependent control and bcl-x(L)-overexpressing FL5.12 cell lines after treatment with MK886, a specific FLAP inhibitor. FL5.12 cells contained a substantial amount of FLAP protein and mRNA but surprisingly had no measurable 5-lipoxygenase protein or 5-, 12-, or 15-lipoxygenase activity. The basal level of FLAP protein in cells overexpressing bcl-x(L) was 70% less than in controls. FLAP disappeared 4 h after withdrawal of interleukin-3 in bcl-x(L) cells but not in control cells, which underwent apoptosis. A dose- and time-response study revealed that 5 nmol of MK886/106 cells was sufficient to induce apoptosis both in control and bcl-x(L) cells, respectively, but to different degrees. bcl-x(L) and bcl-2 proteins, but not bax or FLAP, were decreased by 4 h after 5 nmol of MK886/106 cells in both cell lines, although the higher levels of bcl-x(L) in overexpressors took longer to disappear. This early loss of bcl- x(L) and bcl-2 was not attributable to generalized proteolysis, as shown by Coomassie Blue staining and by the maintenance of bax. Caspase-3 was activated 2 h after MK886 treatment in control cells but not in bcl-x(L) cells. Inhibition of caspase-3 decreased MK886-induced apoptosis by 50% in control cells. Inhibition of this caspase after MK886 treatment was unable to prevent the loss of bcl-x(L) in control cells but did provide partial protection for the loss of the transfected form, but not the endogenous form, in overexpressing cells. These data indicate that MK886 induces extensive apoptosis that is partially caspase-3 dependent and may be related to a rapid loss of bcl-x(L). Although caspase-3 inhibitors had no effect on the loss of bcl-x(L), other caspases or protease systems may still be involved. The absence of 5-lipoxygenase in cells containing FLAP, the lower level of FLAP in bcl-x(L) cells, the apoptosis-inducing activity of MK886, and the rapid loss of bcl-x(L) and bcl-2 proteins after treatment with MK886 strongly indicate that FLAP has activities unrelated to lipoxygenase and suggest a possible functional or regulatory link between these proteins, which share similar subcellular localizations.

Original languageEnglish (US)
Pages (from-to)28163-28169
Number of pages7
JournalJournal of Biological Chemistry
Issue number43
StatePublished - Oct 23 1998
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'A relationship between 5-lipoxygenase-activating protein and bcl-x(L) expression in murine pro-B lymphocytic FL5.12 cells'. Together they form a unique fingerprint.

Cite this